• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Accounting Officer Cohen Amir was granted 41,786 shares and covered exercise/tax liability with 20,497 shares, increasing direct ownership by 21% to 121,342 units (SEC Form 4)

    11/5/25 4:52:29 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary
    Get the next $SRTA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Cohen Amir

    (Last) (First) (Middle)
    C/O STRATA CRITICAL MEDICAL, INC.
    31 HUDSON YARDS, 14TH FLOOR

    (Street)
    NEW YORK NY 10001

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Strata Critical Medical, Inc. [ SRTA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Accounting Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    10/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A common stock, $0.0001 par value per share 10/31/2025 A 41,786(1) A $0 141,839 D
    Class A common stock, $0.0001 par value per share 11/03/2025 F 20,497(2) D $5.03 121,342 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
    2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
    Remarks:
    /s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen 11/05/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SRTA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRTA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Strata Critical Medical Announces Third Quarter 2025 Results

    Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 million, reaffirmed Adjusted EBITDA rangeInvestor Day scheduled for November 17th 2025; will introduce 2026 guidance and medium term financial targets NEW YORK, Nov. 1

    11/10/25 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces Date for Third Quarter Ending September 30, 2025 Earnings Release Conference Call

    NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the third quarter ended September 30, 2025 on Monday, November 10, 2025 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will b

    10/9/25 4:16:38 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Announces 2025 Investor Day

    NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (NASDAQ:SRTA, ", Strata", or the ", Company", )), formerly known as Blade Air Mobility, Inc. (NASDAQ:BLDE), will hold an Investor Day at the Nasdaq MarketSite in New York City on Monday, November 17th 2025. The event will begin at 2:00pm ET and will include presentations by members of the management team. Investors and analysts can register for the Investor Day on the events section of Strata's Investor Relations website that can be found here. A live video webcast and presentation materials will be available on the day of the event at ir.stratacrtical.com. About Strata Critical Medical Strata is a time-critical

    9/30/25 4:00:00 PM ET
    $BLDE
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Cohen Amir was granted 41,786 shares and covered exercise/tax liability with 20,497 shares, increasing direct ownership by 21% to 121,342 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    11/5/25 4:52:29 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Co-CEO and General Counsel Tomkiel Melissa M. was granted 208,929 shares and covered exercise/tax liability with 106,659 shares, increasing direct ownership by 8% to 1,372,642 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    11/5/25 4:52:21 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Co-CEO and CFO Heyburn William A. was granted 181,072 shares and covered exercise/tax liability with 100,133 shares, increasing direct ownership by 6% to 1,386,436 units (SEC Form 4)

    4 - Strata Critical Medical, Inc. (0001779128) (Issuer)

    11/5/25 4:52:08 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    SEC Filings

    View All

    SEC Form 10-Q filed by Strata Critical Medical Inc.

    10-Q - Strata Critical Medical, Inc. (0001779128) (Filer)

    11/10/25 11:51:14 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Strata Critical Medical, Inc. (0001779128) (Filer)

    11/10/25 7:06:04 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Strata Critical Medical Inc.

    SCHEDULE 13G/A - Strata Critical Medical, Inc. (0001779128) (Subject)

    11/4/25 5:07:38 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    $SRTA
    Financials

    Live finance-specific insights

    View All

    Strata Critical Medical Announces Third Quarter 2025 Results

    Revenue increased 36.7% year-over-year to $49.3 million in Q3 2025 and grew 29.0% excluding the impact of the Keystone acquisition Net loss increased to $(9.7) million in Q3 2025 versus $(5.6) million in the prior year periodMedical Segment Adjusted EBITDA increased 93.5% in Q3 2025 to $7.6 million versus the prior year period and increased 80.2% excluding the impact of the Keystone acquisition(1)Medical Segment Adjusted EBITDA margin excluding Keystone increased to 15.1% in Q3 2025(1)Raised 2025 revenue guidance to $185-195 million, reaffirmed Adjusted EBITDA rangeInvestor Day scheduled for November 17th 2025; will introduce 2026 guidance and medium term financial targets NEW YORK, Nov. 1

    11/10/25 7:00:00 AM ET
    $SRTA
    Transportation Services
    Consumer Discretionary

    Strata Critical Medical Announces Date for Third Quarter Ending September 30, 2025 Earnings Release Conference Call

    NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical. (NASDAQ:SRTA, "Strata" or the "Company")), will release financial results for the third quarter ended September 30, 2025 on Monday, November 10, 2025 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata's Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata's Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants. To join the live call, please register here. Upon registration, a dial-in and unique PIN will b

    10/9/25 4:16:38 PM ET
    $SRTA
    Transportation Services
    Consumer Discretionary